Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jeffrey Kindler
Biotech
Kindler's Centrexion restarts IPO bid to fund phase 3 pain trial
The Jeff Kindler-helmed biotech pulled the plug on a planned IPO late last year but now hopes to find investors more amenable to its plans.
Nick Paul Taylor
Sep 19, 2019 9:05am
Centrexion farms out pain drug to Lilly in deal worth up to $998M
May 28, 2019 4:20pm
Opentrons raises $10M, rolls out $4K lab automation device
Mar 27, 2018 9:00am
Kindler’s Centrexion raises $67M to fund phase 3 pain trial
Jan 2, 2018 8:01am
Kindler’s Centrexion posts knee pain data as phase 3 nears
Jun 14, 2017 10:26am
Pharma Two B raises $30M for Parkinson's phase 3
Feb 27, 2017 7:34am
